Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Acute Ischemic Stroke Patients Undergoing Endovascular Revascularization
NCT05367362Phase 2Withdrawn
- Sponsor
- University at Buffalo
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of minocycline in ischemic stroke, sponsored by University at Buffalo. Planned start Dec 2025; status: withdrawn.
02
Drugs
minocycline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05367362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367362.